168 related articles for article (PubMed ID: 8333206)
1. Postpartum factor VIII inhibitors. Report of two cases with special reference to the efficacy of various treatments.
Hauser I; Gisslinger H; Locker G; Elbl W; Kyrle PA; Pabinger I; Lechner K
Wien Klin Wochenschr; 1993; 105(12):355-8. PubMed ID: 8333206
[TBL] [Abstract][Full Text] [Related]
2. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
Meili EO; Dazzi H; von Felten A
Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
[TBL] [Abstract][Full Text] [Related]
3. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.
Huang YW; Saidi P; Philipp C
Haemophilia; 2004 Nov; 10(6):713-21. PubMed ID: 15569166
[TBL] [Abstract][Full Text] [Related]
4. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
[TBL] [Abstract][Full Text] [Related]
5. Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment.
Hauser I; Schneider B; Lechner K
Thromb Haemost; 1995 Jan; 73(1):1-5. PubMed ID: 7740477
[TBL] [Abstract][Full Text] [Related]
6. [Recurrent bleeding tendency due to factor VIII inhibitor during therapy for bullous pemphigoid].
Kuboki T; Kudo T; Iwata N; Morimoto I
Rinsho Ketsueki; 1999 Oct; 40(10):1087-92. PubMed ID: 10565226
[TBL] [Abstract][Full Text] [Related]
7. Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A.
Pejsa V; Grgurević I; Kusec R; Gaćina P
Croat Med J; 2004 Apr; 45(2):213-6. PubMed ID: 15103761
[TBL] [Abstract][Full Text] [Related]
8. Severe bleeding in a case of acquired factor VIII inhibitor associated with generalized pustular psoriasis.
Merlini M; Moccia F; Delucchi M; Grillo G
Ann Ital Med Int; 2005; 20(4):248-52. PubMed ID: 16610257
[TBL] [Abstract][Full Text] [Related]
9. [Combined treatment with factor VIII and immunosuppressive agents in a young woman with acquired factor VIII inhibitor].
José Aguado M; Carrasco V; Periago A; Bello T; González E; García-Talavera J
Sangre (Barc); 1996 Apr; 41(2):147-50. PubMed ID: 9045356
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
Sultan Y; Brouet JC
Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682
[TBL] [Abstract][Full Text] [Related]
11. [Long-term response to rituximab in a patient with acquired hemophilia].
García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
[TBL] [Abstract][Full Text] [Related]
12. Acquired factor VIII inhibitor associated with prostatic cancer: successful treatment with steroid and immunosuppressive therapy.
Moccia F; Tognoni E; Boccaccio P
Ann Ital Med Int; 2000; 15(2):172-6. PubMed ID: 10920509
[TBL] [Abstract][Full Text] [Related]
13. Acquired factor VIII inhibitors in nonhemophilic patients.
Söhngen D; Specker C; Bach D; Kuntz BM; Burk M; Aul C; Kobbe G; Heyll A; Hollmig KA; Schneider W
Ann Hematol; 1997 Feb; 74(2):89-93. PubMed ID: 9063379
[TBL] [Abstract][Full Text] [Related]
14. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
Kubisz P; Plamenová I; Hollý P; Stasko J
Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
[TBL] [Abstract][Full Text] [Related]
15. [Acquired haemophilia A].
Brouwer RE; Huisman MV; Feuth JD; van der Meer FJ
Ned Tijdschr Geneeskd; 1997 Jul; 141(27):1342-4. PubMed ID: 9380188
[TBL] [Abstract][Full Text] [Related]
16. Acquired hemophilia secondary to factor VIII inhibitors after pregnancy.
Dhôte R; Stieltjes N; Thevenot T; Permal S; Pernin N; Molho P; Christoforov B
Ann Med Interne (Paris); 1998 Sep; 149(5):300-2. PubMed ID: 9791567
[TBL] [Abstract][Full Text] [Related]
17. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
Field JJ; Fenske TS; Blinder MA
Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
[TBL] [Abstract][Full Text] [Related]
18. [Fatal opportunistic infection following disappearance of antibodies by immunosuppressive therapy in a patient with acquired factor VIII inhibitor].
Kubota Y; Sano M; Nakazato S; Tsuneyoshi N; Tomimasu R; Kuwahara N; Fukushima N; Funai N; Suga K; Sueoka E
Rinsho Ketsueki; 2004 Sep; 45(9):1023-7. PubMed ID: 15510829
[TBL] [Abstract][Full Text] [Related]
19. [Development of factor VIII inhibitor in three non-hemophiliac patients].
Kiguchi T; Niiya K; Yamawaki Y; Shima M; Harada M
Rinsho Ketsueki; 2000 Nov; 41(11):1195-200. PubMed ID: 11193439
[TBL] [Abstract][Full Text] [Related]
20. [Management of patients with Type 2B von Willebrand's disease during delivery and puerperium].
Güth U; Tsakiris DA; Reber A; Holzgreve W; Hösli I
Z Geburtshilfe Neonatol; 2002; 206(4):151-5. PubMed ID: 12198592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
